EXEMESTANE TEVA 25 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

EXEMESTANE

Available from:

ABIC MARKETING LTD, ISRAEL

ATC code:

L02BG06

Pharmaceutical form:

FILM COATED TABLETS

Composition:

EXEMESTANE 25 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

PHAROS GENERICS LTD, CYPRUS

Therapeutic group:

EXEMESTANE

Therapeutic area:

EXEMESTANE

Therapeutic indications:

Exemestane Teva® is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Exemestane Teva® is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies.Exemestane Teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy

Authorization date:

2018-05-31

Patient Information leaflet

PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
EXEMESTANE TEVA 25 MG
FILM-COATED TABLETS
COMPOSITION
Each film-coated tablet contains:
Exemestane 25 mg.
For a list of the inactive ingredients, please see section 6, and
also see section 2 “Important information about some of the
ingredients of the medicine”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE
MEDICINE. This leaflet contains concise information about the
medicine. If you have further questions, refer to the doctor
or pharmacist. This medicine has been prescribed for the
treatment of your ailment. Do not pass it on to others. It
may harm them, even if it seems to you that their ailment
is similar.
This medicine is not intended for children.
1.
WHAT IS THE MEDICINE INTENDED FOR?
Exemestane Teva 25 mg is used to treat early-stage hormone-
dependent breast cancer in postmenopausal women after
they have already completed 2-3 years of treatment with the
medicine tamoxifen.
In addition, Exemestane Teva 25 mg is used to treat advanced
hormone-dependent breast cancer in postmenopausal
)naturally or induced) women, whose disease progressed
after a single hormonal treatment or after several hormonal
treatments )anti-estrogenic).
THERAPEUTIC GROUP:
Steroidal inhibitors of the aromatase enzyme, anti-neoplastic
)anti-cancer) agents.
Exemestane Teva 25 mg belongs to a group of aromatase
inhibitors - the enzyme needed, especially in postmenopausal
women, to produce the female sex hormones, estrogens.
Reduction in estrogen levels in the body is a way of treating
hormone-dependent breast cancer.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF YOU ARE:
- Sensitive )allergic) or have been sensitive in the past,
to the active ingredient )exemestane) or to any of the
additional ingredients contained in the medicine )for
further information please see section 6)
- Pregnant, may be pregnant or breastfeeding
- Before menopause )you still have mo